Physician profile
Mitesh K Patel
NPI 1093987034
$7,197.83
in general payments reported to CMS, 2019-2025
14 companies · $551 in 2025
The $551 reported for 2025 was more than what 84% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $3,211 · 2021: $1,783 · 2022: $607 · 2023: $551 · 2024: $255 · 2025: $551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $2,975.00 | 2020 | |
| Ferring Pharmaceuticals INC. | $1,869.16 | 2019-2025 | Euflexxa |
| Bioventus LLC | $939.01 | 2020-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Zimmer Biomet Holdings, INC. | $564.30 | 2022-2025 | Gel-One Cross-Linked Hyaluronate |
| Horizon Therapeutics Plc | $278.21 | 2019-2022 | |
| Boston Scientific Corporation | $192.50 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $142.37 | 2023 | Iovera |
| Depuy Synthes Sales INC. | $68.20 | 2019-2025 | Orthovisc, Monovisc |
| Pacira Therapeutics, INC. | $50.00 | 2019 | |
| Fidia Pharma USA INC. | $33.62 | 2022-2025 | Hymovis |
| Endo Pharmaceuticals INC. | $29.87 | 2019 | |
| Avanos Medical | $20.39 | 2022 | |
| Orthofix Medical, INC. | $19.19 | 2025 | Physio-Stim |
| Abbvie INC. | $16.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.